At the Warsaw edition of SAS Innovate on Tour 2025, future technologies were given a real dimension. The event focused primarily on showing practical applications of artificial intelligence in various sectors. And not in the form of promises – but implementations that are already changing the way banks, insurers or retailers operate today.
The centrepiece of the event was the presentation of the AI Ambassador Award 2025. Five Polish organisations – Bank Gospodarstwa Krajowego, DOZ Direct, ING Bank Śląski, Polski Światłowód Otwarty and the Insurance Guarantee Fund – were honoured for their use of AI to build market advantages. Importantly, it was not about experiments in laboratories, but about concrete implementations: fraud detection, service personalisation, risk management. The academic sector also received a distinction – the SAS Educator Award went to Dr Agnieszka Kucharska from the Warsaw University of Technology, highlighting the importance of competence and education in the field of data.
Against the backdrop of many industry events, SAS Innovate stands out for its consistency – not only in its ‘AI trusted and accountable’ rhetoric, but also in its technological offering. The company does not run away into buzzwords, but shows solutions that combine modernity with pragmatism. Quantum AI is an example – not a futuristic vision, but a concrete proposition for companies struggling with multidimensional analytics. Already 60% of companies in the UK and China are actively testing or investing in such approaches – SAS clearly wants Poland not to be left behind.
Another interesting theme was the integration of digital twins into the Unreal Engine. While it may sound like a marketing ploy, the use of realistic 3D models to test business operations has potential: especially in manufacturing, logistics or retail, where margins of error cost real money.
SAS has also demonstrated the growing importance of synthetic data – particularly relevant to privacy. The ability to train AI models on artificially generated datasets could become crucial in regulated industries such as medicine or finance.
